78676454
Jul 22, 2005
Oct 2, 2007
Active Trademark
Pharmaceuticals for the Treatment of Acute Exposure to Blood Containing HBsAg, Perinatal Exposure of Infants Born to HBsAg-Positive Mothers, Sexual Exposure to HBsAg Positive Persons and Household Exposure to Persons With Acute HBV Infection
Pharmaceuticals